Article Versions Notes

Hsu H-H, Kuo W-W, Shih H-N, Cheng S-F, Yang C-K, Chen M-C, Tu C-C, Viswanadha VP, Liao P-H, Huang C-Y. FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer. Cancers. 2019; 11(10):1576. https://doi.org/10.3390/cancers11101576

Hsu, Hsi-Hsien, Wei-Wen Kuo, Hui-Nung Shih, Sue-Fei Cheng, Ching-Kuo Yang, Ming-Cheng Chen, Chuan-Chou Tu, Vijaya Padma Viswanadha, Po-Hsiang Liao, and Chih-Yang Huang. 2019. "FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer" Cancers 11, no. 10: 1576. https://doi.org/10.3390/cancers11101576

Hsu, H.-H., Kuo, W.-W., Shih, H.-N., Cheng, S.-F., Yang, C.-K., Chen, M.-C., Tu, C.-C., Viswanadha, V. P., Liao, P.-H., & Huang, C.-Y. (2019). FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer. Cancers, 11(10), 1576. https://doi.org/10.3390/cancers11101576